[Treatment of mitral MRSA endocarditis using daptomycin]

Med Mal Infect. 2008 Dec:38 Spec No 2:13-5. doi: 10.1016/S0399-077X(08)75154-0.
[Article in French]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Bacteremia / drug therapy
  • Bacteremia / microbiology
  • Combined Modality Therapy
  • Daptomycin / pharmacology
  • Daptomycin / therapeutic use*
  • Device Removal
  • Drug Therapy, Combination
  • Endocarditis, Bacterial / drug therapy*
  • Endocarditis, Bacterial / microbiology
  • Endocarditis, Bacterial / surgery
  • Fatal Outcome
  • Female
  • Gentamicins / administration & dosage
  • Gentamicins / therapeutic use
  • Hip Prosthesis / adverse effects*
  • Humans
  • Methicillin-Resistant Staphylococcus aureus / drug effects*
  • Methicillin-Resistant Staphylococcus aureus / isolation & purification
  • Mitral Valve / microbiology*
  • Mitral Valve / pathology
  • Mitral Valve / surgery
  • Postoperative Complications / etiology
  • Prosthesis-Related Infections / drug therapy*
  • Prosthesis-Related Infections / microbiology
  • Prosthesis-Related Infections / surgery
  • Respiratory Distress Syndrome / etiology
  • Rifampin / administration & dosage
  • Rifampin / therapeutic use
  • Staphylococcal Infections / drug therapy*
  • Staphylococcal Infections / microbiology
  • Staphylococcal Infections / surgery
  • Thrombocytopenia / chemically induced
  • Vancomycin / administration & dosage
  • Vancomycin / adverse effects
  • Vancomycin / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Gentamicins
  • Vancomycin
  • Daptomycin
  • Rifampin